Pharmafile Logo
Pharmafocus logo
Advanced Search

Business Services

Pharmaceutical Business Services – News, analysis and company profiles

Showing 15 posts of 2465 posts found.

BMS acquires Mirati Therapeutics for $4.8bn

October 9, 2023 Business Services BMS, Mirati Therapeutics, Oncology, acquisition, bristol myers squibb, oncology

Bristol Myers Squibb (BMS) and Mirati Therapeutics have announced that they have entered into a definitive agreement under which BMS …
News

FUJIFILM Diosynth Biotechnologies appoints Maja Pedersen as chief quality officer

October 6, 2023 Business Services Fujifilm, Fujifilm Diosynth Biotechnologies, Maja Pedersen, Pharmacy, appointment, chief quality officer

CEO and president of FUJIFULM Diosynth Biotechnologies Lars Petersen has appointed Maja Pedersen as chief quality officer, where she will …
Appointment

Janssen and Sanofi enter agreement for potential vaccine programme

October 5, 2023 Business Services Immunology, Janssen, Sanofi, e coli, vaccines

Janssen Pharmaceuticals, a Johnson & Johnson company, has announced a development and commercialisation agreement with Sanofi for Janssen’s extraintestinal pathogenic …
News

Eli Lilly to acquire POINT Biopharma

October 4, 2023 Business Services Eli Lilly, Oncology, POINT Biopharma, acquisition, oncology

Eli Lilly and POINT Biopharma have announced a definitive agreement for Lilly to acquire POINT to expand its pipeline of …
News

Austrian state secretary to speak at FlyPharma Europe 2023

September 29, 2023 Business Services FlyPharma 2023, Vienna, flypharma

29 September 2023 — London, UK — FlyPharma Europe will welcome Mr Florian Tursky, the Austrian state secretary, to the …
News
Press release

Avalyn Pharma raises $175m in Series C financing for inhalation therapies

September 28, 2023 Business Services Avalyn Pharma, Financing, Pharmacy, funding, inhalation therapies

US-based clinical stage biopharmaceutical company Avalyn Pharma has announced that it has raised $175m in Series C financing to continue …
News

Alfasigma to acquire Intercept Pharmaceuticals for $19 per share

September 27, 2023 Business Services Alfasigma, Gastrointestinal tract, acquisition

Alfasigma and Intercept Pharmaceuticals have announced that they have entered into a definitive merger agreement, meaning Alfasigma will acquire Intercept …
News

Acesion Pharma raises €45m series B funding

September 26, 2023 Business Services Acesion Pharma, Cardiology, atrial fibrillation, series B financing

Acesion Pharma has announced that it has closed an oversubscribed €45m series B financing round. This financing was co-led by …
News

Exscientia enters AI drug discovery collaboration with Merck KGaA

September 20, 2023 Business Services AI, Exscientia, Immunology, Merck KGaA, Neurology, Oncology, collaboration, drug discovery

Exscientia has announced a new collaboration with Merck KGaA, Darmstadt, Germany, with a focus on the discovery of novel small …
News

Abbott to acquire Bigfoot Biomedical

September 6, 2023 Business Services Abbott, Bigfoot Biomedical, Diabetes, acquisition, diabetes

Abbott and Bigfoot Biomedical have announced a definitive agreement for Abbott to acquire Bigfoot, however this transaction is still subject …
News

Novo Nordisk acquires Embark Biotech and its lead metabolic programme

August 31, 2023 Business Services Cardiology, Novo Nordisk, Obesity, acquisition, metabolics, obesity

Novo Nordisk has officially acquired the biopharmaceutical company Embark Biotech, along with its lead asset metabolic programme. The teams will …
News

CN Bio introduces Dr Tomasz Kostrzewski as new chief scientific officer

August 31, 2023 Business Services CN Bio, CSO, Dr Tomasz Kostrzewski, Microbiology

On 30August 2023, CN Bio announced the appointment of Dr Tomasz Kostrzewski as chief scientific officer (CSO) – a new …
Appointment

LEO Pharma to acquire Timber Pharmaceuticals for up to $36m

August 22, 2023 Business Services Dermatology, LEO Pharma, Timber Pharmaceuticals, acquisition

Timber Pharmaceuticals has announced that it has entered a definitive agreement to be acquired by LEO Pharma, with a total …
News

Destiny Pharma appoints new CEO Chris Tovey

August 21, 2023 Business Services CEO, Chris Tovey, Destiny Pharma, Infections and infestations

Destiny Pharma has announced the appointment of Chris Tovey, who will be replacing Dr Debra Barker as chief executive officer; …
Appointment

Dr Michael Lutz appointed as new chief executive officer of iotaSciences

August 18, 2023 Business Services Dr Michael Lutz, Haematology, chief executive officer, iotasciences

The pharmaceutical discovery company iotaSciences has announced that it has appointed Dr Michael Lutz as its new chief executive officer. …
Appointment
The Gateway to Local Adoption Series

Latest content

Pharma sees climate disruption as growing supply-chain risk

September 11, 2026

Manchester NHS-MHRA partnership to test new technologies in real-world care

September 10, 2026

Ondine reports 40% reduction in surgical-site infections in phase 3 trial

September 9, 2026

Northern Ireland to roll out staff well-being training across health service

September 8, 2026

European consortium demonstrates continuous manufacturing platform for pharmaceutical ingredients

September 7, 2026